2006
DOI: 10.1016/j.cca.2006.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Pro-inflammatory states and IGF-I level in ischemic heart disease with low or high serum iron

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
9
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 26 publications
1
9
0
Order By: Relevance
“…Eccentric cardiac hypertrophy, in which chamber volume enlarges without a relative increase or even with a relative decrease in its wall thickness, is known to progress to dilated cardiomyopathy, heart failure and sudden death (Rossi & Carillo, 1991; Nicol et al 2001). Accumulating evidence indicates that pro‐inflammatory cytokines and growth factors play pathogenic roles in myocardial remodelling processes, including cardiac hypertrophy and apoptosis, in various cardiac diseases (Neyses & Pelzer, 1995; Hirano, 1998; Lee et al 2006 a , c ). Tumour necrosis factor‐α (TNFα) and insulin‐like growth factor (IGF)‐II have also been implicated in the pathophysiology of cardiac hypertrophy (Lee et al 2006 b ).…”
mentioning
confidence: 99%
“…Eccentric cardiac hypertrophy, in which chamber volume enlarges without a relative increase or even with a relative decrease in its wall thickness, is known to progress to dilated cardiomyopathy, heart failure and sudden death (Rossi & Carillo, 1991; Nicol et al 2001). Accumulating evidence indicates that pro‐inflammatory cytokines and growth factors play pathogenic roles in myocardial remodelling processes, including cardiac hypertrophy and apoptosis, in various cardiac diseases (Neyses & Pelzer, 1995; Hirano, 1998; Lee et al 2006 a , c ). Tumour necrosis factor‐α (TNFα) and insulin‐like growth factor (IGF)‐II have also been implicated in the pathophysiology of cardiac hypertrophy (Lee et al 2006 b ).…”
mentioning
confidence: 99%
“…In HD patients, increased ferritin levels reflect a decrease in iron‐specific antioxidant activity and represents a risk factor for advanced cardiovascular damage 27 . Our previous study also show that higher cardiovascular risks are associated with elevated serum ferritin in IHD patients 9 . Also, low TIBC is a risk factor for cardiovascular diseases 11 .…”
Section: Discussionmentioning
confidence: 82%
“…Our previous study showed that IHD patients with lower serum iron have a higher cardiovascular risk than IHD patients with normal serum iron. 9 Increased serum ferritin has been associated with cardiovascular mortality and was also suggested as an independent predictor of cardiovascular mortality. 10,27 In HD patients, increased ferritin levels reflect a decrease in iron-specific antioxidant activity and represents a risk factor for advanced cardiovascular damage.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Blockade of inflammatory cytokines has been shown to be effective in preventing the alteration in sepsis-induced IGF levels [16, 18], suggesting inflammatory cytokines can repress this important protein synthesis signaling pathway. In addition, increased levels of inflammatory cytokines, concomitant with decreased activity of the IGF system, have been observed in aging [20], chronic inflammation [20], inflammatory bowel disease [21], and ischemic heart disease [22], conditions also associated with muscle protein loss. In addition, pro-inflammatory cytokines have also been shown to promote protein degradation [23].…”
Section: Introductionmentioning
confidence: 99%